Robert B Jones - Net Worth and Insider Trading

Robert B Jones Net Worth

The estimated net worth of Robert B Jones is at least $4,126 dollars as of 2024-05-02. Robert B Jones is the President and CEO of Acura Pharmaceuticals Inc and owns about 412,555 shares of Acura Pharmaceuticals Inc (ACUR) stock worth over $4,126. Details can be seen in Robert B Jones's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert B Jones has not made any transactions after 2017-12-14 and currently still holds the listed stock(s).

Transaction Summary of Robert B Jones

To

Robert B Jones Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert B Jones owns 1 companies in total, including Acura Pharmaceuticals Inc (ACUR) .

Click here to see the complete history of Robert B Jones’s form 4 insider trades.

Insider Ownership Summary of Robert B Jones

Ticker Comapny Transaction Date Type of Owner
ACUR Acura Pharmaceuticals Inc 2020-01-02 President & CEO

Robert B Jones Latest Holdings Summary

Robert B Jones currently owns a total of 1 stock. Robert B Jones owns 412,555 shares of Acura Pharmaceuticals Inc (ACUR) as of December 14, 2017, with a value of $4,126.

Latest Holdings of Robert B Jones

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACUR Acura Pharmaceuticals Inc 2017-12-14 412,555 0.01 4,126

Holding Weightings of Robert B Jones


Robert B Jones Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert B Jones has made a total of 0 transactions in Acura Pharmaceuticals Inc (ACUR) over the past 5 years. The most-recent trade in Acura Pharmaceuticals Inc is the acquisition of 400,000 shares on December 14, 2017, which cost Robert B Jones around $40,000.

Insider Trading History of Robert B Jones

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert B Jones Trading Performance

GuruFocus tracks the stock performance after each of Robert B Jones's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert B Jones is 67.65%. GuruFocus also compares Robert B Jones's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert B Jones within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert B Jones's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert B Jones

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 58.82
Relative Return to S&P 500(%) 53.76

Robert B Jones Ownership Network

Ownership Network List of Robert B Jones

No Data

Ownership Network Relation of Robert B Jones


Robert B Jones Owned Company Details

What does Acura Pharmaceuticals Inc do?

Who are the key executives at Acura Pharmaceuticals Inc?

Robert B Jones is the President & CEO of Acura Pharmaceuticals Inc. Other key executives at Acura Pharmaceuticals Inc include VP & Corporate Development James F Emigh , VP & Treasurer & Controller Robert A Seiser , and VP Pharmaceutical Sciences APT Albert W Brzeczko .

Acura Pharmaceuticals Inc (ACUR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Acura Pharmaceuticals Inc (ACUR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acura Pharmaceuticals Inc (ACUR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acura Pharmaceuticals Inc (ACUR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Acura Pharmaceuticals Inc Insider Transactions

No Available Data

Robert B Jones Mailing Address

Above is the net worth, insider trading, and ownership report for Robert B Jones. You might contact Robert B Jones via mailing address: C/o Acura Pharmaceuticals, Inc. 616 N North Court Palatine Il 60067.

Discussions on Robert B Jones

No discussions yet.